No products in the cart.
U.S. FILLED & FINISHED | ≥99% COA-VERIFIED PURITY
LC-MS VERIFIED IDENTITY | INDEPENDENTLY TESTED
Prohormone processing is how the body solves a problem the laboratory solves differently: making a precise, active peptide. Where synthetic chemistry builds a peptide amino acid by amino acid on a resin, the body instead builds an oversized, inactive precursor and then cuts it down to size. This guide explains how that precursor-and-cleavage system works, using insulin as the model example.
How the Body Makes Its Own Peptides: Prohormone Processing
Synthetic chemistry builds a peptide one amino acid at a time on a resin. The body does something almost the opposite: it builds an oversized, inactive precursor protein first, then cuts it down into the finished, active peptide. This precursor-and-cleavage strategy, called prohormone processing, is how nearly every peptide hormone in the body is actually made.
The Prohormone Theory
In 1967, two research groups independently arrived at the same conclusion: active peptide hormones are not made directly. They are cleaved out of larger, inactive precursor proteins. Donald Steiner observed that a human insulin-producing tumor was generating a larger, higher-molecular-weight form of insulin that was later converted into the mature hormone, leading him to propose the existence of proinsulin. At the same time, Michel Chrétien, working from sequence similarities between several pituitary peptides, concluded that active hormones are released from larger precursors by cleavage at pairs of basic amino acids [1]. Both lines of evidence converged on the same mechanism, now known as the prohormone theory, which remains the foundation for how peptide hormone biosynthesis is understood today.
Research framing: This article explains endogenous peptide biosynthesis in an educational, research context. Compounds referenced elsewhere on this site are supplied by Badger Compounds for laboratory research use only and are not intended for human or veterinary use. Nothing here is medical advice.
From Precursor to Active Peptide: The General Pattern
Across the many peptide hormones that follow this pattern, the same basic sequence of events applies.
1. Signal Peptide Cleavage
The initial precursor is translated with a short signal sequence that directs it into the cell’s secretory pathway, then removed by a signal peptidase.
2. Folding
The resulting prohormone folds, often forming disulfide bonds that lock its structure in place before it is packaged for processing.
3. Enzymatic Cleavage
Specialized enzymes cut the prohormone at specific sites, typically pairs of basic amino acids, releasing the active peptide from the rest of the precursor.
4. Trimming
Additional enzymes remove any leftover basic residues left behind at the new cut ends, finishing the mature peptide.
Insulin as the Model Example
Insulin remains the clearest illustration of this whole process. It begins as preproinsulin, a single-chain precursor containing a signal peptide followed by the insulin B-chain, a connecting segment called C-peptide, and the insulin A-chain, in that order. After the signal peptide is removed and the chain folds into proinsulin, specific enzymes called prohormone convertases cut the precursor at two internal sites, releasing C-peptide and leaving the insulin A and B chains still joined by the disulfide bonds formed during folding. The result is mature, two-chain insulin, plus the free C-peptide, both released together from pancreatic beta cells [1]. This same precursor logic underlies the peptide-vs-hormone relationship discussed in our post on peptide vs hormone.
The body never makes a peptide hormone directly. It makes something too big to be active, then trims it down at exact, enzyme-defined positions. Precision comes from cutting, not from building each residue one at a time.
Beyond Insulin: A General Biological Strategy
This same precursor-cleavage logic extends well beyond insulin. Many neuropeptides and hormones, including several processed in the pituitary gland, are cut from larger precursor proteins by the same family of proprotein convertase enzymes, sometimes yielding more than one distinct active peptide from a single starting precursor [1]. The specific cleavage sites and the enzymes that recognize them differ by tissue and by peptide, but the underlying pattern, oversized precursor in, precisely cut active peptide out, repeats throughout the body’s endocrine and neuroendocrine systems.
Biological Processing vs Laboratory Synthesis
It is worth contrasting this natural process with how research peptides are actually manufactured. Solid-phase peptide synthesis builds a peptide directly, one amino acid at a time, rather than carving it out of a larger precursor, which is why a synthetic research peptide does not go through anything resembling prohormone processing. For that side of the story, see our overview of how research peptides are made.
Research Concepts Related to Prohormone Processing
Preproinsulin and proinsulin Signal peptide cleavage Proprotein convertases Dibasic cleavage sites C-peptide Endogenous peptide biosynthesisExplore Research-Grade Peptides – ≥99% (HPLC)
Every compound in our catalog is synthesized domestically, six-round independently tested per batch, and supported by publicly viewable COAs. For qualified laboratory research use only.
Browse the Catalog- Chrétien M. How the prohormone theory solved two important controversies in hormonal and neural peptide biosynthesis. Front Endocrinol (Lausanne). 2013;4:148. PMC3805937
Disclaimer: This article is for informational and educational purposes only. Products discussed elsewhere on this site are research use only, not for human consumption, veterinary use, clinical use, or any consumer application. Statements have not been evaluated by the FDA. This content does not provide medical advice.
